In June 2023, we had the privilege of joining T.J. Waggoner and other eye care professionals on a clinic visit to then APCO Vice President Dr. Rajeev Prasad’s Visual Eyez. Despite the odds, Dr. Prasad’s innovative approach, blending therapy and psychology, has transformed the lives of his patients who were previously deemed untreatable. Get ready to be inspired as we explore how Dr. Prasad is redefining vision care with his infectious optimism, passion, and ingenuity. The post Inside Visual Eyez: The Inspiring Work of Dr. Rajeev Prasad appeared first on COOKIE ..read more

Is repeated low-level red-light therapy (RLRL) the next big thing in myopia control? Join Prof. Mingguang He from The Hong Kong Polytechnic University as he discusses his work on the efficacy, safety and future of RLRL—and why he thinks it’s brighter than ever.  RLRL is an at-home, low-level laser treatment that leverages the therapeutic properties of red light to influence axial length growth. The body of evidence supporting its use to control axial length growth in myopia is growing—so head to the Eyerising International website (https://www.eyerisinginternational.com/) to learn more a ..read more

On March 21st, a research team from Waterloo University in Ontario, Canada, announced the formulation of a new biomaterial that could be made into a contact lens to speed up the process of postoperative ocular wound healing. And that’s just one of many intriguing potential applications in the human body. The biomaterial, called GelMA+, is a unique formulation of collagen-derivative gelatin methacrylate. GelMA+ would be used as the basis of a combination ophthalmic bandage lens and targeted-release drug delivery system.  “The technology is activated by enzymes released when the eye is in a ..read more

In the latest move in the United States to expand optometry’s scope of practice, South Dakota has now authorized ODs statewide to perform ophthalmic laser treatments and injections.  Governor Kristi Noem gave optometrists the nod on March 5, with authorization starting July 1 of this year. The newly passed legislation, South Dakota’s House Bill 1099 (HB 1099), brings intradermal injections, selective laser trabeculoplasty (SLT), and ytrium-aluminum-garnett (YAG) laser capsulotomies within the purview of South Dakota’s optometry practice. The bill also adds educational requirements for op ..read more

Celebrating its 10th edition, 100% Optical 2024 drew nearly 10,000 industry professionals from around the globe to the vibrant city of London. From groundbreaking tech to the latest trends, join CEO Matt Young as he unveils the conference’s top moments. A special thanks to all those who took the time to chat with us: Dr. Ian Beasley, Dr. Sunil Mamtora, Sarah Westen, Lorcan Butler, Dr. Radhika Rampat, Sophie Sanderson, Annaliese Dayes, Jason Robinson, Joy Julius and Jorge Fernandez. Don’t miss out—subscribe to Media MICE for more conference updates! The post 100% Optical Rewind: Eyeconic Momen ..read more

A war of words between a well-respected researcher and an established device manufacturer over the safety of repeated low-level red light (RLRL) devices for childhood myopia has escalated, putting the myopia control technology front and center. Australia-based firm Eyerising International, producer of a leading red light therapy device, issued a press release on Feb 3 taking exception with a study published in Ophthalmic & Physiological Optics (OPO) on safety issues over RLRL therapy.   The article in question was penned by Dr. Lisa A. Ostrin and Dr. Alexander W. Schill from the ..read more

Optical coherence tomography angiography, or OCT-A, is the (relatively) new kid on the OCT block, and it’s starting to attract buzz in surprising places. OCT-A tracks blood flow in various layers of the retina to produce three dimensional scans of the microvasculature in the back of the eye. Unsurprisingly, a cascade of research has followed its debut, showcasing the technology’s significant promise in screening for, managing, understanding and treating a host of retinal diseases. Glaucoma, then, might seem like a surprising place for OCT-A to show up. But Dr. Jacqueline Chua, an associate pro ..read more

Dr. Nadia Afkhami, a first-generation Iranian-American optometrist, has gained recognition as one of the winners of the 2022 Eyecare Business Game Changer Awards. Passionate about making a tangible difference in the industry, she embraces technology and social media to connect with patients, boasting over 16.9K followers on Instagram. Approachable, determined, and creative, Dr. Nadia Afkhami loves establishing a connection with people and changing their lives with something as simple as an eye exam. “I am deeply passionate about making a tangible difference in people’s lives by optimizing thei ..read more

The perception of eyeglasses has evolved over time—and in Western populations, eyeglasses have become more popular. Has a similar shift occurred in other societies, such as the Arab world—and could this have implications for the growing rates of myopia? A Jordanian study could hold the answers. When it comes to fashion, there’s only one constant— change. You know that from your own experience. There’s no doubt there are a few pictures from your teenage years that you’d rather block out from memory, whether that’s because you were wearing some rather bizarre clothing or sporting an ill-advised ..read more

Rogers, Arkansas, 26 January 2024 Waggoner Diagnostics today announced the inclusion of its Computerized Color Vision Test (CCVT) on Olleyes, Inc.’s (Summit, New Jersey) pioneering VisuALL virtual reality testing device. The partnership will add the color vision testing prowess of Waggoner’s flagship product to the VisuALL’s robust suite of eye care diagnostic products, which already includes visual field perimetry and visual acuity.  A natural fit from the outset Pushing patient outcomes with the trifecta of ease of use, accuracy and reliability is critical to both companies, and this ha ..read more